20%
Highest listed pathwayRequires systemic oral antifungal therapy for a total duration of 6 weeks or more in the past 12 months.
What separates the next level: Highest compensable evaluation defined under this diagnostic code.
Review CFR criteria, examples, and evidence
- Official CFR language
- 38 CFR 4.118, DC 7813 establishes the 20% evaluation criteria.
- Qualification explanation
- Medical records must document the specific functional findings and clinical thresholds corresponding to the 20% level.
- Examples
- Veteran has clinical documentation demonstrating the 20% criteria under 38 CFR 4.118, DC 7813.
- Medical evidence
- Skin Conditions DBQ (VA Form 21-0960F-2); Clinical treatment progress notes; Diagnostic testing reports
- Functional impact examples
- Documented impairment affecting daily physical or occupational performance.
- Common misconceptions
- A clinical diagnosis alone without documented severity does not guarantee a compensable rating.
- Related topics
- tinea-pedis; 38 CFR Part 4; DC 7813